114 related articles for article (PubMed ID: 3715193)
21. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
23. A new model-independent physiological approach to study hepatic drug clearance and its applications.
Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
[TBL] [Abstract][Full Text] [Related]
24. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Ott P; Keiding S; Bass L
Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
[TBL] [Abstract][Full Text] [Related]
25. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.
Wiersma DA; Roth RA
Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365
[TBL] [Abstract][Full Text] [Related]
26. Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
Chalon SA; Desager JP; Desante KA; Frye RF; Witcher J; Long AJ; Sauer JM; Golnez JL; Smith BP; Thomasson HR; Horsmans Y
Clin Pharmacol Ther; 2003 Mar; 73(3):178-91. PubMed ID: 12621383
[TBL] [Abstract][Full Text] [Related]
27. Hepatic and renal clearances of lidocaine in conscious and anesthetized sheep.
Mather LE; Runciman WB; Carapetis RJ; Ilsley AH; Upton RN
Anesth Analg; 1986 Sep; 65(9):943-9. PubMed ID: 3740492
[TBL] [Abstract][Full Text] [Related]
28. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
Egfjord M
Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
[TBL] [Abstract][Full Text] [Related]
29. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
30. Rapid determination of functional liver plasma flow in ICU patients by a modified hepatic D-sorbitol plasma clearance method.
Köppel C; Pohle S; Müller C
Eur J Drug Metab Pharmacokinet; 1993; 18(4):327-31. PubMed ID: 8020530
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of procainamide N-acetylation in the rat in vivo and in the perfused rat liver preparation.
Pang KS; Huang JC; Finkle C; Kong P; Cherry WF; Fayz S
Drug Metab Dispos; 1984; 12(3):314-22. PubMed ID: 6203693
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 470():1-330. PubMed ID: 12579203
[TBL] [Abstract][Full Text] [Related]
33. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
34. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
35. Measurement of liver blood flow by galactose clearance.
Hanna SS
Can J Surg; 1984 May; 27(3):218-20. PubMed ID: 6722669
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
Yu VC; de Lamirande E; Horning MG; Pang KS
Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
[TBL] [Abstract][Full Text] [Related]
37. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
Terao N; Shen DD
J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
[TBL] [Abstract][Full Text] [Related]
38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
39. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
40. Extrarenal sorbitol clearance after liver transplantation.
Paintaud G; Miguet JP; Bresson-Hadni S; Gillet M; Mantion G; Bechtel P
Therapie; 1992; 47(1):47-51. PubMed ID: 1523594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
